49
|
164
|
8hz8A |
Structure of ppia in complex with the peptide of nrf2 |
20
|
107
|
8vk3E |
Structure of mouse ryr1 in complex with s100a1 (egta-only dataset) |
18
|
169
|
8qo9W |
Cryo-em structure of a human spliceosomal b complex protomer |
38
|
155
|
7oxhA |
Ttslyd with pseudo-wild-type s2 peptide |
30
|
150
|
7oxkA |
Ttslyd with w4k pseudo-wild-type s2 peptide |
28
|
108
|
8x6pA |
Isomerase protein |
64
|
209
|
7l6yA |
Crystal structure of the peptidyl-prolyl cis-trans isomerase (ppib) from streptococcus pyogenes. |
61
|
214
|
7l6zA |
Crystal structure of peptidyl-prolyl cis-trans isomerasefrom (ppib) streptococcus pneumoniae r6 |
60
|
267
|
7l75A |
Crystal structure of peptidylprolyl isomerase prsa from streptococcus mutans. |
27
|
172
|
7eu35 |
Chloroplast ndh complex |
32
|
128
|
7apwA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylethyl)-3,10-diazabicyclo[4.3.1]decan-2-one |
24
|
145
|
7wg5i |
Cyclic electron transport supercomplex ndh-psi from arabidopsis |
34
|
128
|
7apqA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylmethyl)-3,10-diazabicyclo[4.3.1]decan-2-one |
32
|
173
|
7wg5j |
Cyclic electron transport supercomplex ndh-psi from arabidopsis |
31
|
173
|
7wffj |
Subcomplexes b,m and l in the cylic electron transfer supercomplex ndh-psi from arabidopsis |
35
|
127
|
7aptA |
The fk1 domain of fkbp51 in complex with ((1s,5s,6r)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-vinyl-3,10-diazabicyclo[4.3.1]decan-3-yl)acetic acid |
34
|
150
|
7oxiA |
Ttslyd with w4a pseudo-wild-type s2 peptide |
35
|
156
|
7oxjA |
Ttslyd with m8a pseudo-wild-type s2 peptide |
20
|
145
|
7wffi |
Subcomplexes b,m and l in the cylic electron transfer supercomplex ndh-psi from arabidopsis |
19
|
102
|
7oxgA |
Ttslyd fkbp domain with m8a pseudo-wild-type s2 peptide |
41
|
166
|
6l2bA |
Crystal structure of cyclophilin mutant i164m from leishmania donovani at 2.65 angstrom resolution |
27
|
172
|
7f9od |
Psi-ndh supercomplex of barley |
45
|
158
|
7efxA |
Crystal structure of human pin1 complexed with covalent inhibitor |
33
|
128
|
7etvA |
The fk1 domain of fkbp51 in complex with peptide-inhibitor hit dfpfv |
28
|
117
|
7f2jA |
Crystal structure of atfkbp53 fkbd in complex with rapamycin |
50
|
158
|
7efjA |
Crystal structure analysis of human pin1 |
32
|
127
|
7etuA |
The fk1 domain of fkbp51 in complex with peptide-inhibitor hit sfpft |
46
|
158
|
7f0mA |
Crystal structure of human pin1 complexed with a potent covalent inhibitor |
50
|
158
|
7ekvA |
Crystal structure of human pin1 complexed with a covalent inhibitor |
32
|
127
|
7ettA |
The fk1 domain of fkbp51 in complex with peptide-inhibitor hit qfpfv |
26
|
107
|
7dkiA |
Silk worm fkbp, isoform-1 |
19
|
107
|
8uq3E |
Structure of human ryr2-s2808d in the closed state in the presence of arm210 |
15
|
93
|
7zexA |
Complex cyp33-rrmdelta alpha : uaaugucg rna |
19
|
117
|
7zevA |
Free form of extended cyp33-rrm |
19
|
117
|
7zewA |
Complex cyp33-rrm : aauaaa rna |
24
|
107
|
7tzcF |
A drug and atp binding site in type 1 ryanodine receptor |
42
|
165
|
7n9xGGG |
Ca-targeting nanobody is a tool for studying hiv-1 capsid lattice interactions |
48
|
164
|
7pcjA |
X-ray structure of cypa-c52ak125c/csa/aromatic foldamer complex |
19
|
107
|
8chlA |
Human fkbp12 in complex with (1s,5s,6r)-9-((3,5-dichlorophenyl)sulfonyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,9-diazabicyclo[4.2.1]nonan-2-one |
30
|
127
|
8chqA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-((s)-3,5-dichloro-n-methylphenylsulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
26
|
107
|
8chkA |
Human fkbp12 in complex with (1s,5s,6r)-10-((s)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
31
|
128
|
8chpA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-((s)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
24
|
107
|
8chmA |
Human fkbp12 in complex with (1s,5s,6r)-10-((s)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
30
|
128
|
8chrA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-((r)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
23
|
107
|
8chiA |
Human fkbp12 in complex with (1s,5s,6r)-10-((s)-3,5-dichloro-n-methylphenylsulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
30
|
128
|
8chnA |
The fk1 domain of fkbp51 in complex with (1s,5s,6r)-10-((s)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
24
|
107
|
8chjA |
Human fkbp12 in complex with (1s,5s,6r)-10-((r)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one |
51
|
163
|
8bk4A |
Full length structure of the apo-state lpmip. |
36
|
134
|
8bk5A |
A structure of the truncated lpmip with bound inhibitor jk095. |
25
|
113
|
8bk6A |
A truncated structure of lpmip with bound inhibitor jk095. |